Eric Rose - SIGA Technologies Chairman of the Board, CEO
| SIGA Stock | USD 8.51 0.42 4.70% |
Chairman
Dr. Eric A. Rose, M.D. serves as Executive Chairman of the Board of the Company. On January 13, 2012, Dr. Roses existing employment agreement was amended. Pursuant to the amended employment agreement, we agreed to pay to Dr. Rose an annual base salary of 700, 000, subject to any cost of living adjustments as may be approved by our Board of Directors. Under the terms of this employment agreement, Dr. Rose was also eligible to receive an annual cash bonus, the target of which was 350, 000, as determined by the Board of Directors in its sole discretion. On April 12, 2016, in connection with the effective date of the POR, Dr. Roses employment agreement was amended and restated. Pursuant to the amended and restated agreement, Dr. Roses base salary increased to 787, 856 and Dr. Rose became eligible for an annual cash bonus equivalent to 100 percent of base salary. On October 13, 2016, Dr. Rose employment agreement was further amended and restated in connection with Dr. Roses transition from Chief Executive Officer to Executive Chairman of the Board . Pursuant to the October 2016 Amended and Restated Rose Agreement, Dr. Roses base salary was adjusted to 740, 000. Additionally, Dr. Rose was issued 300, 000 restricted stock units in November 2016, pursuant to the terms of the October 2016 Amended and Restated Agreement. since 2016.
| Age | 67 |
| Tenure | 8 years |
| Phone | 212 672 9100 |
| Web | https://www.siga.com |
SIGA Technologies Management Efficiency
The company has return on total asset (ROA) of 0.2326 % which means that it generated a profit of $0.2326 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.3709 %, meaning that it created $0.3709 on every $100 dollars invested by stockholders. SIGA Technologies' management efficiency ratios could be used to measure how well SIGA Technologies manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 14 records | CHAIRMAN Age | ||
| Satish Reddy | Dr Reddys Laboratories | 52 | |
| Chinh Chu | Catalent | 48 | |
| David Stack | Pacira Pharmaceuticals | 74 | |
| William Rastetter | Neurocrine Biosciences | 69 | |
| David Hoover | Elanco Animal Health | 72 | |
| Zhilin Li | China Pharma Holdings | 71 | |
| Craig Stapleton | Avadel Pharmaceuticals PLC | 70 | |
| G Prasad | Dr Reddys Laboratories | 59 | |
| Jack Bendheim | Phibro Animal Health | 77 | |
| Roger Newton | Esperion Therapeutics | 67 | |
| John Chiminski | Catalent | 60 | |
| Richard Pops | Alkermes Plc | 62 | |
| Bryan Roberts | Ironwood Pharmaceuticals | 47 | |
| Michael Heffernan | Collegium Pharmaceutical | 53 | |
Management Performance
| Return On Equity | 0.37 | ||||
| Return On Asset | 0.23 |
SIGA Technologies Leadership Team
Elected by the shareholders, the SIGA Technologies' board of directors comprises two types of representatives: SIGA Technologies inside directors who are chosen from within the company, and outside directors, selected externally and held independent of SIGA. The board's role is to monitor SIGA Technologies' management team and ensure that shareholders' interests are well served. SIGA Technologies' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, SIGA Technologies' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Phillip Gomez, CEO | ||
| Jay MD, Chief VP | ||
| Thomas Constance, Independent Director | ||
| Paul Savas, Independent Director | ||
| Andrew Stern, Independent Director | ||
| Jeffrey Kindler, Independent Director | ||
| JD Esq, General Counsel | ||
| Bruce Slovin, Independent Director | ||
| James Antal, Independent Director | ||
| Tove Bolken, Senior Officer | ||
| Michael Bayer, Independent Director | ||
| Todd Fromer, IR Contact Officer | ||
| Herb Vloedman, Senior Officer | ||
| III MD, CEO Director | ||
| Eric Rose, Chairman of the Board, CEO | ||
| Dennis Hruby, Chief Scientific Officer and VP | ||
| Daniel Luckshire, CFO, Principal Accounting Officer, Executive VP and Secretary | ||
| Diem MBA, CEO Director | ||
| Joseph Marshall, Independent Director |
SIGA Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is SIGA Technologies a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.37 | ||||
| Return On Asset | 0.23 | ||||
| Profit Margin | 0.49 % | ||||
| Operating Margin | 0.79 % | ||||
| Current Valuation | 482.05 M | ||||
| Shares Outstanding | 71.09 M | ||||
| Shares Owned By Insiders | 9.39 % | ||||
| Shares Owned By Institutions | 49.43 % | ||||
| Number Of Shares Shorted | 5.14 M | ||||
| Price To Earning | 12.41 X |
Currently Active Assets on Macroaxis
| CRM | Salesforce | |
| TXT | Textron | |
| VECO | Veeco Instruments | |
| AMAT | Applied Materials | |
| CRNT | Ceragon Networks |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in SIGA Technologies. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price. For information on how to trade SIGA Stock refer to our How to Trade SIGA Stock guide.Note that the SIGA Technologies information on this page should be used as a complementary analysis to other SIGA Technologies' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Complementary Tools for SIGA Stock analysis
When running SIGA Technologies' price analysis, check to measure SIGA Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy SIGA Technologies is operating at the current time. Most of SIGA Technologies' value examination focuses on studying past and present price action to predict the probability of SIGA Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move SIGA Technologies' price. Additionally, you may evaluate how the addition of SIGA Technologies to your portfolios can decrease your overall portfolio volatility.
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Stocks Directory Find actively traded stocks across global markets | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |
Is SIGA Technologies' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of SIGA Technologies. If investors know SIGA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about SIGA Technologies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of SIGA Technologies is measured differently than its book value, which is the value of SIGA that is recorded on the company's balance sheet. Investors also form their own opinion of SIGA Technologies' value that differs from its market value or its book value, called intrinsic value, which is SIGA Technologies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because SIGA Technologies' market value can be influenced by many factors that don't directly affect SIGA Technologies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between SIGA Technologies' value and its price as these two are different measures arrived at by different means. Investors typically determine if SIGA Technologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, SIGA Technologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.